Ultravate (halobetasol propionate 0.05 % ) Topical Cream
RxNorm 977992
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 977992 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ultravate (halobetasol propionate 0.05 % ) Topical Cream.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Halobetasol propionate 0.5 mg/ML Topical Cream [Ultravate]
(Atom ID: 3086865)
PSN
Prescribable Name (PSN):
Ultravate (halobetasol propionate 0.05 % ) Topical Cream
(Atom ID: 6373791)
SY
Synonym (SY):
Ultravate (halobetasol propionate 0.05 % ) Topical Cream
(Atom ID: 3307484)
Patient Education
Halobetasol Topical
Halobetasol topical is used to treat redness, swelling, itching, and discomfort of various skin conditions in adults and children 12 years of age and older, including plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). Halobetasol is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
[Learn More]
* Please review the disclaimer below.